<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>ar444</ui>
   <ji>ARJ</ji>
   <fm>
      <dochead>Meeting abstract</dochead>
      <bibl>
         <title>
            <p>Effects of TIMP-1 and TIMP-3 gene transfer on invasiveness, proliferation and apoptosis of rheumatoid arthritis (RA) synovial fibroblasts (RA-SF)</p>
         </title>
         <aug>
            <au id="A1">
               <snm>Pap</snm>
               <fnm>T</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A2">
               <snm>Drynda</snm>
               <fnm>A</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A3">
               <snm>Seemayer</snm>
               <fnm>CA</fnm>
               <insr iid="I2"/>
            </au>
            <au id="A4">
               <snm>Quax</snm>
               <fnm>PHA</fnm>
               <insr iid="I3"/>
            </au>
            <au id="A5">
               <snm>Verheijen</snm>
               <fnm>JH</fnm>
               <insr iid="I3"/>
            </au>
            <au id="A6">
               <snm>Drynda</snm>
               <fnm>S</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A7">
               <snm>Huizinga</snm>
               <fnm>TWJ</fnm>
               <insr iid="I4"/>
            </au>
            <au id="A8">
               <snm>Michel</snm>
               <fnm>BA</fnm>
               <insr iid="I5"/>
            </au>
            <au id="A9">
               <snm>Gay</snm>
               <fnm>RE</fnm>
               <insr iid="I2"/>
            </au>
            <au id="A10">
               <snm>Gay</snm>
               <fnm>S</fnm>
               <insr iid="I2"/>
            </au>
            <au id="A11">
               <snm>van der Laan</snm>
               <fnm>WH</fnm>
               <insr iid="I6"/>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Division of Experimental Rheumatology, Magdeburg, Germany</p>
            </ins>
            <ins id="I2">
               <p>Center of Exp Rheumatology, Zurich, Switzerland</p>
            </ins>
            <ins id="I3">
               <p>TNO Prevention and Health, Leiden, The Netherlands</p>
            </ins>
            <ins id="I4">
               <p>Dept of Rheumatology, Leiden, The Netherlands</p>
            </ins>
            <ins id="I5">
               <p>Dept. Rheumatology, Zurich, Germany</p>
            </ins>
            <ins id="I6">
               <p>TNO Prevention and Health, Leiden, Germany</p>
            </ins>
         </insg>
         <source>Arthritis Res</source>
         <supplement>
            <title>
               <p>22nd European Workshop for Rheumatology Research</p>
            </title>
            <sponsor>
               <note>The organizer would like to thank the following companies who have generously supported the 22nd European Workshop for Rheumatology Research: Abbott/Knoll, MSD, Wyeth Ayerst, Amgen, Centocor, Novartis, Schering Plough, Aventis</note>
            </sponsor>
            <note>Meeting abstracts</note>
         </supplement>
         <conference>
            <title>
               <p>22nd European Workshop for Rheumatology Research</p>
            </title>
            <location>Leiden, The Netherlands</location>
            <date-range>28 February &#8211; 3 March 2002</date-range>
         </conference>
         <issn>1465-9905</issn>
         <pubdate>2002</pubdate>
         <volume>4</volume>
         <issue>Suppl 1</issue>
         <fpage>109</fpage>
         <xrefbib>
            <pubid idtype="doi">10.1186/ar444</pubid>
         </xrefbib>
      </bibl>
      <history>
         <rec>
            <date>
               <day>15</day>
               <month>1</month>
               <year>2002</year>
            </date>
         </rec>
         <pub>
            <date>
               <day>4</day>
               <month>2</month>
               <year>2002</year>
            </date>
         </pub>
      </history>
   </fm>
   <meta>
      <classifications>
         <classification type="BMC" subtype="old_arx_id">ar-4-s1-109</classification>
      </classifications>
   </meta>
   <bdy>
      <sec>
         <st>
            <p/>
         </st>
         <p>TIMPs play a key role in counter balancing the action of MMPs and have been associated with cell proliferation, inhibition of angiogenesis and induction of apoptosis. Here, we investigated the effects of TIMP-1 and TIMP-3 gene transfer on cartilage invasion, proliferation and apoptosis of RA-SF. RA-SF were transduced with an adenoviral vector expressing human TIMP-1 (AdTIMP-1) or TIMP-3 (AdTIMP-3). Transduction efficacy was assessed by LacZ staining of RA-SF that were transduced with an adenoviral &#946;-galactosidase construct. Untransduced and mock transduced RA-SF were used as controls. TIMP-1 was measured by ELISA in the culture supernatants of AdTIMP-1 transduced and mock transduced cells every 10 days until 60 days after transduction. Proliferation was assessed by <sup>3</sup>H-thymidine incorporation, and the rate of spontaneous apoptosis as well as FasL induced cell death was determined by a histon fragmentation assay. AdTIMP-1 and AdTIMP-3 transduced RA-SF and control RA-SF were co-implanted with human articular cartilage under the renal capsule of SCID mice for 60 days and their invasiveness was evaluated on paraffin sections using a semiquantitative score. Transduction efficacy was 67%, and TIMP-1 levels in the supernatants of AdTIMP-1 transduced cells were 51.5 &#177; 6.5 &#956;g/ml as compared to 8.7 &#177; 3.4 &#956;g/ml in the mock transduced cells. These levels of TIMP expression were maintained for at least 60 days. AdTIMP-1 and AdTIMP-3 gene transfer resulted in an inhibition of proliferation (35% and 40% vs. mock, respectively; <it>P</it> &lt; 0.05). Transduction of RA-SF with AdTIMP-3 but not TIMP-1 increased spontaneous apoptosis (+24%; vs. mock, <it>P</it> &lt; 0.05) as well as susceptibility to FasL-induced cell death (+23% vs. mock, <it>P</it> &lt; 0.05). In the SCID mouse model, untransduced and mock transduced RA.SF deeply invaded the cartilage (scores: 2.5 &#177; 0.2 and 3.2 respectively). In the AdTIMP-1 and AdTIMP-3 transduced RA-SF, invasion was inhibited clearly (scores 0.9 &#177; 0.4 and 1.2 &#177; 0.2 respectively) Both AdTIMP-1 and AdTIMP-3 gene transfer inhibit proliferation of RA-SF and reduce cartilage invasion. In contrast to TIMP-1, adenoviral gene transfer with TIMP-3. has a strong pro-apoptotic effect on RA-SF and facilitates Fas mediated cell death. These results indicate that gene transfer of TIMPs may be a useful approach to inhibit joint destruction in RA.</p>
      </sec>
   </bdy>
</art>
